
Oncology NEWS International
- Oncology NEWS International Vol 5 No 5
- Volume 5
- Issue 5
Free PSA Test Awarded US Patent
ABBOTT PARK, Ill--Abbott Laboratories and the Finnish-based company Wallac Oy, a subsidiary of EG&G Inc. (Wellesley, Mass), have received a US patent for two methods of assaying free PSA (prostate-specific antigen).
ABBOTT PARK, Ill--Abbott Laboratories and the Finnish-based companyWallac Oy, a subsidiary of EG&G Inc. (Wellesley, Mass), havereceived a US patent for two methods of assaying free PSA (prostate-specificantigen).
The patent was issued to two inventors, Dr. Ulf-Hakan Stenman,of Helsinki University Central Hospital, and Dr. Hans Lilja, ofLund University.
The inventors gave exclusive rights to Wallac, which subsequentlygranted a sublicense to Abbott. The patent covers immmunoassaysfor free PSA and the use of the ratio of free-to-total PSA tobetter distinguish between prostate cancer and benign prostatichyperplasia (BPH).
Articles in this issue
almost 30 years ago
No Need to Delay Mammography After FNA, Study Showsalmost 30 years ago
Pediatric Cancer Guidelines Are a National Effortalmost 30 years ago
EPA Proposes Changes in Determining Cancer Risk of Chemicals, Pollutantsalmost 30 years ago
ATL's HDI Digital Ultrasound Is Approved for Breast Indicationalmost 30 years ago
NIH Study Suggests That 200 mg Is The Optimal Daily Dose of Vitamin Calmost 30 years ago
Natural History of HIV Supports the Use Of Early Interventionsalmost 30 years ago
Aids Vaccine Trial Fails to Show Clinical Benefitalmost 30 years ago
Rep. Porter Honored For Work on BudgetNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.




































